| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Product Name | Fasiglifam (TAK-875) |
|---|
| Description | Fasiglifam (TAK-875) is a potent and selective agonist of GPR40 with EC50 of 14 nM, 400-fold more potent than oleic acid. TAK-875 displays potent plasma glucose-lowering action and insulinotropic action during an oral glucose tolerance test in female Wistar fatty rats with impaired glucose tolerance. MW: 524.63. Purity ≥97% by HPLC |
|---|
| Size | 5 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | (S)-2-(6-((2',6'-dimethyl-4'-(3-(methylsulfonyl)propoxy)-[1,1'-biphenyl]-3-yl)methoxy)-2,3-dihydrobenzofuran-3-yl)acetic acid |
|---|
| Gene, Accession, CAS # | CAS: 1000413-72-8 |
|---|
| Catalog # | B1280-5 |
|---|
| Price | |
|---|
| Order / More Info | Fasiglifam (TAK-875) from BIOVISION, INC. |
|---|
| Product Specific References | n/a |
|---|
| 產(chǎn)品資料 |
|
|